Public and Scientific Affairs Board

Public and Scientific Affairs Board

VITEK 2 Gram-Positive AST Cards Recalled Due to False Results for Some MRSA Strains: What Can Your Laboratory Do?

The report provides the most recent nationwide data on antibiotic resistance transmitted commonly by food.

Thursday, 23 August 2018 09:54

ASM Attends CPT® Editorial Panel Meeting

Coding and Reimbursement subcommittee member Amy Peace-Brewer represented ASM at the Current Procedural Terminology (CPT®) Editorial Panel on August 9.

ASM joined organizations representing laboratories, diagnostic manufacturers, health care professionals, and patients to urge Congress to take immediate action to address the harmful cuts to the Clinical Laboratory Fee Schedule (CLFS).

On July 26, ASM joined the Clinical Laboratory Coalition (CLC) in a conference call to update members on current strategies to reverse the detrimental effects of the Protecting Access to Medicare Act of 2014 (PAMA) legislation, which will reduce laboratory test reimbursement.

On July 25, the Health Subcommittee of the House Energy and Commerce Committee held a hearing on implementation of the “21st Century Cures Act (Cures Act).” National Institutes of Health (NIH) Director Francis Collins and U.S. Food and Drug Administration (FDA) Commissioner Scott Gottlieb were among the witnesses. Rep. Gene Green (D-TX) expressed concern with antibiotic resistance and development of an Ebola vaccine and Rep. Anna Eshoo (D-CA) asked about the priority review process for medical countermeasures (MCM).

ASM thanks the House Energy and Commerce Committee for its passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018.

ASM joined members of the Clinical Laboratory Coalition in a letter to House and Senate committee leadership on the Diagnostic Accuracy and Innovation Act (DAIA) discussion draft.

ASM staff joined the Global Health Council and other stakeholders in a meeting with Robert Redfield to discuss broad priorities for the CDC in the coming years.

ASM submitted comments to the Centers for Medicare and Medicaid Services on payment for new codes which will be included in the 2019 Medicare Clinical Laboratory Fee Schedule (CLFS). New codes considered include several Borrelia diagnostic tests.

Page 1 of 11